[Resistance studies: when are they indicated?] (Q84028047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

[Resistance studies: when are they indicated?] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M Angeles Marcos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

Infectious Diseases and Clinical Microbiology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

29 Suppl 6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

24-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Antiviral Drug Resistance of Human Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Human cytomegalovirus DNA replication: antiviral targets and drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC/MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Human cytomegalovirus resistance to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

New developments in the management of cytomegalovirus infection after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970053-2

7 January 2021

10.1016/S0213-005X(11)70053-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22541918%20AND%20SRC:MED&resulttype=core&format=json